Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
Nanoparticles represent a potent antigen presentation and delivery system to elicit an optimal immune response by effector cells targeting tumor-associated antigens expressed by cancer cells. Many types of nanoparticles have been developed, such as polymeric complexes, liposomes, micelles and protei...
Main Authors: | Anna Lucia Tornesello, Maria Tagliamonte, Maria Lina Tornesello, Franco M. Buonaguro, Luigi Buonaguro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/4/1049 |
Similar Items
-
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
by: Anna Lucia Tornesello, et al.
Published: (2022-02-01) -
Selecting Target Antigens for Cancer Vaccine Development
by: Luigi Buonaguro, et al.
Published: (2020-10-01) -
Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents
by: Antonella Borrelli, et al.
Published: (2018-01-01) -
Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
by: Angela Mauriello, et al.
Published: (2021-12-01) -
Systems Biology Approach for Cancer Vaccine Development and Evaluation
by: Luisa Circelli, et al.
Published: (2015-07-01)